Canada markets closed

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.73+0.55 (+3.62%)
At close: 04:00PM EDT
15.73 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.23B
Enterprise Value 947.02M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.91
Price/Book (mrq)3.50
Enterprise Value/Revenue 5.80
Enterprise Value/EBITDA -4.53

Trading Information

Stock Price History

Beta (5Y Monthly) 0.38
52-Week Change 31.07%
S&P500 52-Week Change 329.57%
52 Week High 317.73
52 Week Low 39.90
50-Day Moving Average 315.38
200-Day Moving Average 313.99

Share Statistics

Avg Vol (3 month) 3532.73k
Avg Vol (10 day) 3575.27k
Shares Outstanding 580.8M
Implied Shares Outstanding 680.8M
Float 841.33M
% Held by Insiders 130.49%
% Held by Institutions 173.38%
Shares Short (Mar 15, 2024) 45.65M
Short Ratio (Mar 15, 2024) 410.46
Short % of Float (Mar 15, 2024) 49.32%
Short % of Shares Outstanding (Mar 15, 2024) 46.99%
Shares Short (prior month Feb 15, 2024) 45.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -119.34%
Operating Margin (ttm)-106.10%

Management Effectiveness

Return on Assets (ttm)-28.43%
Return on Equity (ttm)-56.29%

Income Statement

Revenue (ttm)163.36M
Revenue Per Share (ttm)1.92
Quarterly Revenue Growth (yoy)32.90%
Gross Profit (ttm)N/A
EBITDA -208.86M
Net Income Avi to Common (ttm)-194.94M
Diluted EPS (ttm)-2.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)306.22M
Total Cash Per Share (mrq)3.79
Total Debt (mrq)25.88M
Total Debt/Equity (mrq)7.37%
Current Ratio (mrq)3.80
Book Value Per Share (mrq)4.36

Cash Flow Statement

Operating Cash Flow (ttm)-146.7M
Levered Free Cash Flow (ttm)-72.79M